BUHLMANN News

Use of basophil activation in oral immunotherapy

New JACI paper from Patil et al: Food allergy is a growing public health burden in children and adults all ...
Read More

CALEX Cap Promotion

BÜHLMANN fCAL® turbo + CALEX® Cap (K191718): FDA 510(k) cleared. For in vitro Diagnostic Use. Health Canada License: 98839 CALEX® Cap CALEX® Cap is an ...
Read More

LabSense News Q1 2020 Edition

In this "Q1 2020 Edition"of BUHLMANN's LabSense News, we are proud to introduce Quantum Blue® Anti-Infliximab (RUO) and Anti-Adalimumab (RUO) to the TDM rapid ...
Read More

Quantum Blue®Anti-Infliximab and Anti-Adalimumab Tests Now Available

New Quantum Blue® TDM Assays BÜHLMANN is proud to introduce Quantum Blue® Anti-Infliximab (RUO) and Anti-Adalimumab (RUO) to the TDM ...
Read More

Flow CAST- Assay Overview Video

Flow CAST®: Research Use Only in the US. Not for diagnostic procedures. Health Canada License:101781 BÜHLMANN Flow CAST® and Basophil ...
Read More

Visit BUHLMANN at CDDW 2020

Canadian Digestive Diseases Week (CDDW) 2020 BUHLMANN Diagnostics Corp Booth: #13 Feb 28 - Mar 1, 2020 | Fairmont Queen ...
Read More

IBDoc Key Literature List

IBDoc® Publications View a compilation of BÜHLMANN IBDoc® calprotectin citations from a wide variety of interesting publications, studies, and posters ...
Read More

100 BÜHLMANN Calprotectin Publications

BÜHLMANN launched its first fecal calprotectin assay over 10 years ago and since then has developed into THE CALPROTECTIN COMPANY ...
Read More